Global market-leading health and care technology company, Tunstall Healthcare has announced the appointment of Peter Nicklin as Chairman of the Board.
Mr Nicklin has a significant international career as a senior healthcare executive with Baxter International, Bayer Healthcare, Novartis and Bristol-Myers Squibb and across a range of sectors, including pharmaceuticals, biologics, vaccines, MedTech, dental, animal health and healthcare services.
Commenting on the announcement, he said: “I’m delighted to be joining Tunstall at such a pivotal time for the digitally connected health and social care industry as there is rapid acceleration in the adoption of digital healthcare worldwide.
“Tunstall is ideally placed to continue to build on its market leading position in the sector throughout the countries it operates. I look forward to working with the Tunstall team to capitalise on opportunities in the market and drive forward its strategy.”
More recently, Mr Nicklin has been CEO and Member of the Board of Amann Girrbach AG based in Koblach, Austria. Currently, he is Chairman of the Board of Versantis, a Swiss pharmaceutical company, as well as Chairman of the Board of Healthcare at Home a leading pharma services company, focused on chronic, rare disease and oncology medicine management services.
Tunstall Group works with health, care and housing providers around the world, providing advanced technology enabled care solutions which enable people with health and care needs to live independently for longer, and with an improved quality of life.
Its technology and service offerings allow its customers to deploy new models of community-based health and care delivery that are more integrated, personalised and proactive.